Indian Pharma Industry to see negative volume growth in 3Q 2025, but will maintain strong gross margins: Report New Delhi, January 13: The Indian pharmaceutical market (IPM) has returned to negative volume growth this Q3FY25 after two consecutive quarters of modest positive growth, according to Goldman Sachs re...
